VEGF Levels in the Alveolar Compartment Do Not Distinguish Between ARDS and Hydrostatic Pulmonary Oedema

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2005 Jul 5

PMID 15994395

Citations 26

Authors

L B Ware

R J Kaner

R G Crystal

R Schane

N N Trivedi

D McAuley

M A Matthay

Affiliations

Soon will be listed here.

Abstract

Although overexpression of vascular endothelial growth factor (VEGF) 165 in the lung causes pulmonary oedema, its role in human acute lung injury (ALI) is unclear. VEGF levels are reported to be lower in bronchoalveolar lavage from ALI patients compared with normals, but these studies did not include a comparably ill control group with noninflammatory pulmonary oedema. The current authors hypothesised that VEGF levels in pulmonary oedema fluid would be lower in ALI patients compared with control patients with severe hydrostatic pulmonary oedema. VEGF was measured in pulmonary oedema fluid and plasma from 56 patients with ALI and 46 controls with severe hydrostatic pulmonary oedema. Pulmonary oedema fluid levels of VEGF did not differ between patients with hydrostatic oedema (median 799 pg x mL(-1), interquartile range (IQR) 226-2,281) and ALI (median 507, IQR 0.8-1,031). Plasma levels were also the same (median 20.5 pg x mL(-1), IQR 0-152 versus 4.8, IQR 0-99.8). There was no association between plasma or oedema fluid VEGF levels and outcomes including mortality. Vascular endothelial growth factor levels in pulmonary oedema fluid were depressed both in acute lung injury and hydrostatic pulmonary oedema. The decrease in air space concentrations of vascular endothelial growth factor in acute lung injury may not be a function of the degree of lung injury, but rather may result from alveolar flooding.

Citing Articles

Effect of Dopamine as a Vascular Endothelial Growth Factor Antagonist on the Development of Acute Lung Injury in Sepsis Patients.

Agarwal S, Srivastava V, Arshad Z, Sharma P, Prakash R Cureus. 2024; 16(7):e64102.

PMID: 39114208 PMC: 11305694. DOI: 10.7759/cureus.64102.

Anti-VEGF Antibody Protects against Alveolar Exudate Leakage Caused by Vascular Hyperpermeability, Resulting in Mitigation of Pneumonitis Induced by Immunotherapy.

Iwai T, Sugimoto M, Patel H, Yorozu K, Kurasawa M, Kondoh O Mol Cancer Ther. 2021; 20(12):2519-2526.

PMID: 34552009 PMC: 9306403. DOI: 10.1158/1535-7163.MCT-21-0031.

Metabolomics: An emerging potential approach to decipher critical illnesses.

Siddiqui M, Pandey S, Azim A, Sinha N, Siddiqui M Biophys Chem. 2020; 267:106462.

PMID: 32911125 PMC: 9986419. DOI: 10.1016/j.bpc.2020.106462.

Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study.

Guillen-Guio B, Lorenzo-Salazar J, Ma S, Hou P, Hernandez-Beeftink T, Corrales A Lancet Respir Med. 2020; 8(3):258-266.

PMID: 31982041 PMC: 7772505. DOI: 10.1016/S2213-2600(19)30368-6.

Mechanosensing and Mechanoregulation of Endothelial Cell Functions.

Fang Y, Wu D, Birukov K Compr Physiol. 2019; 9(2):873-904.

PMID: 30873580 PMC: 6697421. DOI: 10.1002/cphy.c180020.

References

Thickett D, Armstrong L, Christie S, Millar A . Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 164(9):1601-5. DOI: 10.1164/ajrccm.164.9.2011071. View

Maitre B, Boussat S, Jean D, GOUGE M, Brochard L, Housset B . Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J. 2001; 18(1):100-6. DOI: 10.1183/09031936.01.00074701. View

Kaner R, Crystal R . Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med. 2001; 7(4):240-6. PMC: 1950032. View

Kaner R, Ladetto J, Singh R, Fukuda N, Matthay M, Crystal R . Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000; 22(6):657-64. DOI: 10.1165/ajrcmb.22.6.3779. View

Ware L, Matthay M . The acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1334-49. DOI: 10.1056/NEJM200005043421806. View

Monacci W, Merrill M, Oldfield E . Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol. 1993; 264(4 Pt 1):C995-1002. DOI: 10.1152/ajpcell.1993.264.4.C995. View

Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T . Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med. 2002; 166(3):382-5. DOI: 10.1164/rccm.2103112. View

Pham I, Uchida T, Planes C, Ware L, Kaner R, Matthay M . Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2002; 283(5):L1133-42. DOI: 10.1152/ajplung.00464.2001. View

Thickett D, Armstrong L, Millar A . A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med. 2002; 166(10):1332-7. DOI: 10.1164/rccm.2105057. View

10.

Kaner R, Crystal R . Pathogenesis of high altitude pulmonary edema: does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak?. High Alt Med Biol. 2005; 5(4):399-409. DOI: 10.1089/ham.2004.5.399. View

11.

Klekamp J, Jarzecka K, Perkett E . Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol. 1999; 154(3):823-31. PMC: 1866417. DOI: 10.1016/S0002-9440(10)65329-1. View

12.

Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W . Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol. 1998; 140(4):947-59. PMC: 2141756. DOI: 10.1083/jcb.140.4.947. View

13.

Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149(3 Pt 1):818-24. DOI: 10.1164/ajrccm.149.3.7509706. View

14.

ROBERTS W, Palade G . Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995; 108 ( Pt 6):2369-79. DOI: 10.1242/jcs.108.6.2369. View

15.

Miller E, Cohen A, Matthay M . Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med. 1996; 24(9):1448-54. DOI: 10.1097/00003246-199609000-00004. View

16.

Le Gall J, Lemeshow S, Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270(24):2957-63. DOI: 10.1001/jama.270.24.2957. View

17.

Berse B, Brown L, Van de Water L, Dvorak H, Senger D . Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992; 3(2):211-20. PMC: 275520. DOI: 10.1091/mbc.3.2.211. View

18.

Tischer E, Mitchell R, Hartman T, Silva M, GOSPODAROWICZ D, Fiddes J . The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991; 266(18):11947-54. View

19.

Murray J, Matthay M, Luce J, Flick M . An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988; 138(3):720-3. DOI: 10.1164/ajrccm/138.3.720. View

20.

Tang K, Rossiter H, Wagner P, Breen E . Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol (1985). 2004; 97(4):1559-66. DOI: 10.1152/japplphysiol.00221.2004. View